Characterization of autocrine growth factors, their receptors and extracellular matrix present in three-dimensional cultures of DU 145 human prostate carcinoma cells grown in simulated microgravity

Tissue Engineering

Volumn 3, Issue 2, 1997, Pages 161-171

  O'Connor, Kim C ^a   Enmon, Richard M ^a   Dotson, Robert S ^b   Primavera, Amy C ^a   Clejan, Sanda ^b  

^a Tulane University   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LAMININ; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GROWTH REGULATION; HUMAN; HUMAN CELL; MICROGRAVITY; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0030925692     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1997.3.161     Document Type: Article

References (32)

1. Boring, C.C., Squires, T.S., Tong, T., and Montgomery, S. Cancer statistics. CA Cancer J. Clin. 44, 7, 1994.
2. Liu, X-H., Wiley, H.S., and Meikle, A.W. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF)/TGF-a receptor. J. Clin. Endocrinol. Metab. 77, 1472, 1993.
3. Sogani, P.C., and Fair, W.R. Treatment of advanced prostatic cancer. Urol. Clin. North Am. 14, 353, 1987.
4. Gibbons, R.P. Prostate cancer. Cancer 60, 586, 1987.
5. Isaacs, J.T., and Coffey, D.S. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res. 41, 5070, 1981.
6. Gaddipati, J.P., McLeod, D.G., Heindenberg, H.B., Sesterhenn, I.A., Finger, M.J., Moul, J.W., and Srivastaya, S. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res. 54, 2861, 1994.
7. Spaulding, G.F., Jessup, J.M., and Goodwin, T.J. Advances in cellular construction. J. Cell. Biochem. 51, 249, 1993.
8. Glynne-Jones, E., Harper, M.E., Goddard, L., Eaton, C.L., Matthews, P.N., and Griffiths, K. Transforming growth factor beta I expression in benign and malignant prostatic tumors. Prostate 25, 210, 1994.
9. Prewett, T.L., Goodwin, T.J., and Spaulding, G.F. Three-dimensional modeling of T-24 human bladder carcinoma cell line: A new simulated microgravity culture vessel. J. Tiss. Cult. Meth. 15, 29, 1993.
10. Jessup, J.M., Goodwin, T.J., and Spaulding, G. Prospects for use of microgravity-based bioreactors to study three- dimensional host-tumor interactions in human neoplasia. J. Cell. Biochem. 51, 290, 1993.
11. Clejan, S., O'Connor, K.C., Cowger, N.L., Cheles, M.K., Haque, S., and Primavera, A. Effects of simulated microgravity on DU 145 human prostate carcinoma cells. Biotechnol. Bioeng. 50, 587, 1996.
12. Miyamoto, K.K., McSherry, S.A., Dent, G.A., Sar, M., Wilson, E.M., French, F.S., Sharief, Y., and Mohler, J.L. Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue. J. Urol. 149, 1015, 1993.
13. Steiner, M.S. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J. Urol. 153, 1085, 1995.
14. Massagué, J. Receptors for the TGF-β family. Cell 69, 1067, 1992.
15. Nagle, R.B., Hao, J., Knox, J.D., Dalkin, B.L., Clark, V., and Cress, A.E. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am. J. Pathol. 146, 1498, 1995.
16. Peehl, D.M., Leung, G.K., and Wong, S.T., Keratin expression: A measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell. Tissue Res. 277, 11, 1994.
17. Friedman, E. Verderame, M., Winawer, S., and Pollack, R. Actin cytoskeletal organization loss in the benign-to- malignant tumor transition in culture human colonic epithelial cells. Cancer Res. 44, 3040, 1984.
18. Becker, J.L., Prewett, T.L., Spaulding, G.F., and Goodwin, T.J. Three-dimensional growth and differentiation of ovarian tumor cell line in high aspect rotating-wall vessel: Morphologic and embryologic considerations. J. Cell. Biochem. 51, 283, 1993.
19. Jarrard, D.F., Blitz, B.F., Smith, R.C., Patai, B.L., and Rukstalis, D.B. Effect of epidermal growth factor on prostate cancer cell line PC 3 growth and invasion. Prostate 24, 46, 1994.
20. MacDonald, A., and Habib, F.K. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br. J. Cancer 65, 177, 1992.
21. Fong, C.-J., Sherwood, E.R., Mendelsohn, J., Lee, C., and Kozlowski, J.M. Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor α. Cancer Res. 52, 5887, 1992.
22. Kearsley, J.H., Furlong, K.L., Cooke, R.A., and Walters. M.J. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br. J. Cancer 61, 821, 1990.
23. Morita, T., Yoshizumi, M., Kurihara, H., Maemura, K., Nagai, R., and Yazaki, Y. Shear stress increases heparin- binding epidermal growth factor-like growth factor mRNA levels in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 197, 256, 1993.
24. Peppelenbosch, M.P., Tertoolen, L.G.J., Hage, W.J., and de Laat, S.W. Epidermal growth factor-induced actin re- modeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 74, 565, 1993.
25. Morton, D.M., and Barrack, E.R. Modulation of transforming growth factor β1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res. 55, 2596, 1995.
26. Goldstein, D., O'Leary, M., Mitchen, J., Borden, B.C., and Wilding, G. Effects of interferon βser and transforming growth factor β on prostatic cell lines. J. Urol. 146, 1173, 1991.
27. Koff, A., Ohtuski, M., Polyak, K., Roberts, J.M., and Massagué, J. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase and TGFβ. Science 260, 536, 1993.
28. Steiner, M.S., and Barrack, E.R. Transforming growth factor-β1 overproduction in prostate cancer: Effect on growth in vivo and in vitro. Mol. Endocrinol. 6, 15, 1992.
29. Wilding, G., Zugmeier, G., Knabbe, C., Flanders, K., and Gelmann, E. Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol. Cell. Endocrinol. 62, 79, 1989.
30. Fuchs, M.E., Brawer, M.K., Rennels, M.A., and Nagle, R.B. The relationship of basement membrane to histologic grade of human prostatic carcinoma. Mod. Pathol. 2, 105, 1989.
31. Sinha, A.A., Gleason, D.F., DeLeon, O.F., Wilson, M.J., Limas, C., Reddy, P.K., and Furcht, L.T. Localization of type IV collagen in the basement membranes of human prostate and lymph nodes by immunoperoxidase and immunoalkaline phosphatase. Prostate 18, 93, 1991.
32. Francis, K.M., O'Connor, K.C., and Spaulding, G.F. Cultivation of fall armyworm ovary cells in simulated microgravity. In Vitro Cell. Dev. Biol. 33, 332, 1997.